HEAT Trial

Bifunctional antibody against EGFR and TGF Beta, alone and in combination with pembrolizumab for Head and neck cancer, NSCLC and anal cancer and cutaneous squamous cell cancer
Status:

Open

Contact:

Dr. Ari Birnbaum
abirnbaum@lifespan.org